- MRKR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13D Filing
Marker Therapeutics (MRKR) SC 13DMarker Therapeutics, Inc.
Filed: 19 Oct 18, 5:09pm
SCHEDULE 13D |
EXHIBIT 3
JOINT FILING AGREEMENT
Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13D to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the undersigned. This Agreement may be executed in one or more counterparts.
Date: October 19, 2018
AISLING CAPITAL IV, LP | ||
By: Aisling Capital Partners IV, LP, As its General Partner | ||
By: Aisling Capital Partners IV LLC, As its General Partner | ||
By: | /s/ Andrew Schiff | |
Name: Andrew Schiff Title: Managing Member |
AISLING CAPITAL PARTNERS IV, LP | ||
By: Aisling Capital Partners IV LLC, As its General Partner | ||
By: | /s/ Andrew Schiff | |
Name: Andrew Schiff Title: Managing Member |
AISLING CAPITAL PARTNERS IV LLC | ||
By: | /s/ Andrew Schiff | |
Name: Andrew Schiff Title: Managing Member |
STEVE ELMS | ||
By: | /s/ Steve Elms |
ANDREW SCHIFF | ||
By: | /s/ Andrew Schiff |